Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Oilminerdeluxeon Nov 19, 2023 2:40am
214 Views
Post# 35743080

RE:RE:RE:50 millions sharks shares...

RE:RE:RE:50 millions sharks shares...If the FDA suddenly wants 18 month confirmation from the fourteen CR patients, there must be a reason for that. And if they like what they see, that simply must have a positve impact on their decisions. It might speed things up even. I know it is hard to believe the words speed and TLT in the same sentence, but if FDA makes such a request, there must be something to follow that request if it is seen as a positive one,  If those 14 patients are mostly still CR, there must be some kind of a reward. Question is how many of those 14 have now reached their 18 months? And how many are left? Perhaps we will see some info of worth on the matter in the next data update/Q-report. Although, why would anything go smoothly for us, lol. Here's to hoping. 
<< Previous
Bullboard Posts
Next >>